Results 271 to 280 of about 1,392,484 (364)

Medical Management of Polycystic Liver Disease: A Position Statement From the European Reference Network on Hepatological Diseases

open access: yesLiver International, Volume 46, Issue 1, January 2026.
ABSTRACT Polycystic liver disease (PLD) is a rare genetic disorder characterised by progressive liver enlargement due to multiple cysts. The main symptoms are liver volume‐related. Although randomised controlled trials have shown that somatostatin analogues (SSAs) reduce liver volume as well as symptoms, specific guidance on when and how to use SSAs in
Sophia Heinrich   +16 more
wiley   +1 more source

Impact of Minimal Steroid Doses on Post‐Transplant Growth in Pediatric Kidney Recipients, a Retrospective Observational Study

open access: yesPediatric Transplantation, Volume 30, Issue 1, January 2026.
In our study of 44 pediatric kidney transplant recipients, low‐dose corticosteroid therapy was associated with improvements in post‐transplant height and height Z‐scores over 1 year. Growth was not significantly impaired by low‐dose steroids, although a slight downward trend in Z‐scores was observed with increasing steroid doses.
Ochoa‐García Carolina Lucia   +6 more
wiley   +1 more source

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract The therapeutic landscape for renal cell carcinoma (RCC) and urinary tract cancer (UTC) has transformed dramatically, creating complexity in treatment selection and sequencing. The 2025 Advanced Urologic Cancer Consensus Conference was convened to establish evidence‐based expert consensus recommendations for optimal management.
Rana R. McKay   +53 more
wiley   +1 more source

Home - About - Disclaimer - Privacy